Evidence map›Paper›PMID 39204426›Full record

ReviewPharmaceutics2024

Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence.

Dhakshila Niyangoda, Mohammed Muayad, Wubshet Tesfaye, Mary Bushell, Danish Ahmad, Indira Samarawickrema, Justin Sinclair, Shida Kebriti, Vincent Maida, Jackson Thomas

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Beyond Cannabidiol: The Contribution ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dhakshila NiyangodaFaculty of Health, University of Canberra, Canberra, ACT 2617, Australia.ORCID 0000-0002-5206-6381
Mohammed MuayadFaculty of Health, University of Canberra, Canberra, ACT 2617, Australia.
Wubshet TesfayeSchool of Pharmacy, Faculty of Health and Behavioural Sciences, University of Queensland, Queensland, QLD 4072, Australia.ORCID 0000-0001-7208-2330
Mary BushellFaculty of Health, University of Canberra, Canberra, ACT 2617, Australia.ORCID 0000-0002-9262-0113
Danish AhmadSchool of Medicine and Psychology, Australian National University, Canberra, ACT 2601, Australia.
Indira SamarawickremaStrategy Coaching and Research Consulting Pty Ltd., O'Malley, ACT 2606, Australia.
Justin SinclairAustralian Natural Therapeutics Group, Byron Bay, NSW 2481, Australia.
Shida KebritiEczanes Pharmaceuticals, Rydalmere, NSW 2116, Australia.
Vincent MaidaTemerity Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Jackson ThomasFaculty of Health, University of Canberra, Canberra, ACT 2617, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review critically evaluates preclinical and clinical data on the antibacterial and wound healing properties of cannabinoids in integument wounds. Comprehensive searches were conducted across multiple databases, including CINAHL, Cochrane library, Medline, Embase, PubMed, Web of Science, and LILACS, encompassing records up to May 22, 2024. Eighteen studies met the inclusion criteria. Eleven were animal studies, predominantly utilizing murine models (

Indexed as

antibacterialantimicrobial resistancecannabinoidsmedicinal cannabiswound healing

Identifiers

PMID39204426
PMCPMC11359183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.